A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Singapore

DiabCare Asia 2008. A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in Asia and To Evaluate Perceptions and Practices of Physicians and Patients About Diabetes Management in Asia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00836030

Acronym

DiabCare Asia

Enrollment

854

Registered

2009-02-04

Start date

2009-01-31

Completion date

2009-04-30

Last updated

2016-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Brief summary

This study is conducted in Asia. The aim of this observational study is to evaluate current status of diabetes management, control and complications in diabetic subjects in Asia.

Interventions

OTHERNo treatment given

No treatment given

Study design

Observational model

ECOLOGIC_OR_COMMUNITY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Diabetic patients registered in the particular centre for more than 12 months * Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit * Patients willing to sign informed consent form

Exclusion criteria

* Repetition of any patient as patients should not be included twice for any reason * Unwilling to participate or unable to comply with protocol requirements

Design outcomes

Primary

Measure	Time frame
Percentage of diabetic patients having diabetic eye complications	at baseline visit/study start
Percentage of diabetic patients having dyslipidemia and hypertension	at baseline visit/study start
Percentage of diabetic patients having cardiovascular complications	at baseline visit/study start
Percentage of diabetic patients having peripheral vascular disease	at baseline visit/study start
Percentage of diabetic patients having diabetic nephropathy	at baseline visit/study start
Mean age of onset of type 1 and 2 diabetes mellitus	at baseline visit/study start
Mean duration of treatment of type 2 DM	at baseline visit/study start
Percentage of patients on Insulin and OAD therapy	at baseline visit/study start
Mean duration of diabetes in type 1 and type 2 patients respectively	at baseline visit/study start
Mean FPG and PPG of diabetic patients	at baseline visit/study start
Mean HbA1c of diabetic patients	at baseline visit/study start
Percentage of diabetic patients with HbA1c target below or equal to 7.0%	at baseline visit/study start
Percentage of diabetic patients with HbA1c target below or equal to 6.5%	at baseline visit/study start

Secondary

Measure	Time frame
Physician perception of diabetes and its management will be analysed through Physician questionnaire measuring awareness about - HbA1c test and its goal, Anti-diabetic treatment, Barriers towards optimum diabetes control	at baseline visit/study start
Duration of diabetes associated with highest number of diabetic complications	at baseline visit/study start
Minimum duration of diabetes associated with 10% incidence of diabetic complications (CVD, Nephropathy and retinopathy)	at baseline visit/study start
Patients' perception will be analysed through Patient questionnaire measuring - Psychological well-being, Quality of life, Patients' compliant to treatment	at baseline visit/study start

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026